Gilead Sciences (NASDAQ: GILD) reported Q3 EPS of $1.90, $0.38 better than the analyst estimate of $1.52. Revenue for the quarter came in at $7 billion versus the consensus estimate of $6.13 billion.

For earnings history and earnings-related data on Gilead Sciences (GILD) click here.